121 related articles for article (PubMed ID: 1796181)
1. CCK and PYY do not participate in the delayed inhibition of pancreatic secretion, after stimulation by duodenal oleic acid infusion.
Issoual D; Berger Z; Laugier R
Regul Pept; 1991 Oct; 36(1):45-57. PubMed ID: 1796181
[TBL] [Abstract][Full Text] [Related]
2. Hormonal mechanism of sodium oleate-stimulated pancreatic secretion in rats.
Li P; Lee KY; Chang TM; Chey WY
Am J Physiol; 1990 Dec; 259(6 Pt 1):G960-5. PubMed ID: 2260665
[TBL] [Abstract][Full Text] [Related]
3. Role of secretin and cholecystokinin in oleic acid-stimulated pancreatic secretion in rats.
Shiratori K; Watanabe S; Takeuchi T; Shimizu K; Moriyoshi Y
Gastroenterol Jpn; 1990 Feb; 25(1):104-11. PubMed ID: 1689684
[TBL] [Abstract][Full Text] [Related]
4. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
Gabryelewicz A; Kulesza E; Konturek SJ
Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
[TBL] [Abstract][Full Text] [Related]
5. Effect of natural peptide YY on pancreatic secretion and cholecystokinin release in conscious dogs.
Hosotani R; Inoue K; Kogire M; Tatemoto K; Mutt V; Suzuki T; Rayford PL; Tobe T
Dig Dis Sci; 1989 Mar; 34(3):468-73. PubMed ID: 2920652
[TBL] [Abstract][Full Text] [Related]
6. Role of endogenous secretin and cholecystokinin in intraduodenal oleic acid-induced inhibition of gastric acid secretion in rats.
Shiratori K; Watanabe S; Takeuchi T
Dig Dis Sci; 1992 Mar; 37(3):397-402. PubMed ID: 1735364
[TBL] [Abstract][Full Text] [Related]
7. Action of oleic acid on the exocrine pancreatic secretion of the conscious rat: evidence for an anti-cholecystokinin-pancreozymin factor.
Laugier R; Sarles H
J Physiol; 1977 Sep; 271(1):81-92. PubMed ID: 915835
[TBL] [Abstract][Full Text] [Related]
8. Comparison of vasoactive intestinal peptide and secretin in stimulation of pancreatic secretion.
Konturek SJ; Pucher A; Radecki T
J Physiol; 1976 Feb; 255(2):497-509. PubMed ID: 1255530
[TBL] [Abstract][Full Text] [Related]
9. Importance of cholecystokinin in peptide-YY release in response to pancreatic juice diversion.
Guan D; Rivard N; Maouyo D; Gettys TW; Morisset J
Regul Pept; 1993 Feb; 43(3):169-76. PubMed ID: 8441822
[TBL] [Abstract][Full Text] [Related]
10. Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids.
Koop I; Schindler M; Bosshammer A; Scheibner J; Stange E; Koop H
Gut; 1996 Nov; 39(5):661-7. PubMed ID: 9026479
[TBL] [Abstract][Full Text] [Related]
11. Role of secretin and CCK in the stimulation of pancreatic secretion in conscious dogs. Effects of atropine and somatostatin.
Konturek SJ; Konturek JW; Lamers CB; Tasler J; Bilski J
Int J Pancreatol; 1987 Aug; 2(4):223-35. PubMed ID: 2890695
[TBL] [Abstract][Full Text] [Related]
12. Meal-induced peptide tyrosine tyrosine inhibition of pancreatic secretion in the rat.
Aponte GW; Park K; Hess R; Garcia R; Taylor IL
FASEB J; 1989 Jun; 3(8):1949-55. PubMed ID: 2721855
[TBL] [Abstract][Full Text] [Related]
13. Effect of bombesin and related peptides on the release and action of intestinal hormones on pancreatic secretion.
Konturek SJ; Król R; Tasler J
J Physiol; 1976 Jun; 257(3):663-72. PubMed ID: 950608
[TBL] [Abstract][Full Text] [Related]
14. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
[TBL] [Abstract][Full Text] [Related]
15. Effect of a novel cholecystokinin receptor antagonist, FK480, administered intraduodenally, on pancreatic secretion in rats.
Moriyoshi Y; Shiratori K; Takeuchi T; Watanabe S
Pancreas; 1995 Apr; 10(3):295-300. PubMed ID: 7542771
[TBL] [Abstract][Full Text] [Related]
16. The effect of CR 1409, a potent CCK receptor antagonist, on basal and stimulated pancreatic secretion in rat.
Takács T; Nagy I; Pap A; Varró V
Pancreas; 1990; 5(1):60-4. PubMed ID: 2293712
[TBL] [Abstract][Full Text] [Related]
17. The anti-CCK effect of glutaramic acid derivatives in anesthetized and conscious rats.
Takács T; Nagy I; Pap A; Varró V
Pancreas; 1988; 3(4):465-70. PubMed ID: 3174609
[TBL] [Abstract][Full Text] [Related]
18. Comparison of effects of neurotensin and fat on pancreatic stimulation in dogs.
Konturek SJ; Jaworek J; Cieszkowski M; Pawlik W; Kania J; Bloom SR
Am J Physiol; 1983 Jun; 244(6):G590-8. PubMed ID: 6305210
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of CR-1409, a competitive inhibitor of cholecystokinin, on pancreatic exocrine secretion in the conscious rat.
Miyasaka K; Nakamura R; Funakoshi A; Kitani K
Tohoku J Exp Med; 1988 Jun; 155(2):165-72. PubMed ID: 3212779
[TBL] [Abstract][Full Text] [Related]
20. Peptide YY inhibits pancreatic secretion by inhibiting cholecystokinin release in the dog.
Lluis F; Gomez G; Fujimura M; Greeley GH; Thompson JC
Gastroenterology; 1988 Jan; 94(1):137-44. PubMed ID: 3335285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
